CARBIOS Announces AGM Results and New Joint Venture

On June 22, 2026, biotechnology company CARBIOS released the outcomes of its Annual General Meeting held on June 18, 2026, in Clermont-Ferrand. The meeting saw a 27.72% shareholder turnout, with resolutions receiving over 87% approval.

A key highlight was the announcement of a joint venture with Wankai. The new entity, Kaibio Biotechnology Co. Ltd, will build and operate China’s first PET biorecycling plant under a licensing agreement. CARBIOS maintains full patent ownership despite granting technology usage rights.

Chairwoman Isabelle Parize expressed gratitude for shareholder support, emphasizing the company's technological advances in enzymatic recycling. She highlighted the licensing model as instrumental for long-term value creation.

The CARBIOS Board, as of June 19, consists of eight directors, including four independents, and announced forthcoming disclosure of detailed voting results on its website.